Evaluation of arecoline hydrobromide toxicity after a 14-day repeated oral administration in Wistar rats.
A subchronic toxicity test was conducted in rats on the basis of a previous acute toxicity test to evaluate the safety of arecoline hydrobromide (Ah), to systematically study its pharmacological effects and to provide experimental support for a safe clinical dose. Eighty rats were randomly divided i...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4399984?pdf=render |
| _version_ | 1818051233146994688 |
|---|---|
| author | Xiaojuan Wei Jiyu Zhang Jianrong Niu Xuzheng Zhou Jianyong Li Bing Li |
| author_facet | Xiaojuan Wei Jiyu Zhang Jianrong Niu Xuzheng Zhou Jianyong Li Bing Li |
| author_sort | Xiaojuan Wei |
| collection | DOAJ |
| description | A subchronic toxicity test was conducted in rats on the basis of a previous acute toxicity test to evaluate the safety of arecoline hydrobromide (Ah), to systematically study its pharmacological effects and to provide experimental support for a safe clinical dose. Eighty rats were randomly divided into four groups: a high-dose group (1000 mg/kg), medium-dose group (200 mg/kg), low-dose group (100mg/kg) and blank control group. The doses were administered daily via gastric lavage for 14 consecutive days. There were no significant differences in the low-dose Ah group compared to the control group (P>0.05) with regard to body weight, organ coefficients, hematological parameters and histopathological changes. The high-dose of Ah influenced some of these parameters, which requires further study. The results of this study indicated that a long-term, continuous high dose of Ah was toxic. However, it is safe to use Ah according to the clinically recommended dosing parameters. The level of Ah at which no adverse effects were observed was 100 mg/kg/day under the present study conditions. |
| first_indexed | 2024-12-10T11:06:06Z |
| format | Article |
| id | doaj.art-8cc1a6d67af845c89e109e8537b0961f |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-10T11:06:06Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-8cc1a6d67af845c89e109e8537b0961f2022-12-22T01:51:33ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01104e012016510.1371/journal.pone.0120165Evaluation of arecoline hydrobromide toxicity after a 14-day repeated oral administration in Wistar rats.Xiaojuan WeiJiyu ZhangJianrong NiuXuzheng ZhouJianyong LiBing LiA subchronic toxicity test was conducted in rats on the basis of a previous acute toxicity test to evaluate the safety of arecoline hydrobromide (Ah), to systematically study its pharmacological effects and to provide experimental support for a safe clinical dose. Eighty rats were randomly divided into four groups: a high-dose group (1000 mg/kg), medium-dose group (200 mg/kg), low-dose group (100mg/kg) and blank control group. The doses were administered daily via gastric lavage for 14 consecutive days. There were no significant differences in the low-dose Ah group compared to the control group (P>0.05) with regard to body weight, organ coefficients, hematological parameters and histopathological changes. The high-dose of Ah influenced some of these parameters, which requires further study. The results of this study indicated that a long-term, continuous high dose of Ah was toxic. However, it is safe to use Ah according to the clinically recommended dosing parameters. The level of Ah at which no adverse effects were observed was 100 mg/kg/day under the present study conditions.http://europepmc.org/articles/PMC4399984?pdf=render |
| spellingShingle | Xiaojuan Wei Jiyu Zhang Jianrong Niu Xuzheng Zhou Jianyong Li Bing Li Evaluation of arecoline hydrobromide toxicity after a 14-day repeated oral administration in Wistar rats. PLoS ONE |
| title | Evaluation of arecoline hydrobromide toxicity after a 14-day repeated oral administration in Wistar rats. |
| title_full | Evaluation of arecoline hydrobromide toxicity after a 14-day repeated oral administration in Wistar rats. |
| title_fullStr | Evaluation of arecoline hydrobromide toxicity after a 14-day repeated oral administration in Wistar rats. |
| title_full_unstemmed | Evaluation of arecoline hydrobromide toxicity after a 14-day repeated oral administration in Wistar rats. |
| title_short | Evaluation of arecoline hydrobromide toxicity after a 14-day repeated oral administration in Wistar rats. |
| title_sort | evaluation of arecoline hydrobromide toxicity after a 14 day repeated oral administration in wistar rats |
| url | http://europepmc.org/articles/PMC4399984?pdf=render |
| work_keys_str_mv | AT xiaojuanwei evaluationofarecolinehydrobromidetoxicityaftera14dayrepeatedoraladministrationinwistarrats AT jiyuzhang evaluationofarecolinehydrobromidetoxicityaftera14dayrepeatedoraladministrationinwistarrats AT jianrongniu evaluationofarecolinehydrobromidetoxicityaftera14dayrepeatedoraladministrationinwistarrats AT xuzhengzhou evaluationofarecolinehydrobromidetoxicityaftera14dayrepeatedoraladministrationinwistarrats AT jianyongli evaluationofarecolinehydrobromidetoxicityaftera14dayrepeatedoraladministrationinwistarrats AT bingli evaluationofarecolinehydrobromidetoxicityaftera14dayrepeatedoraladministrationinwistarrats |